GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (FRA:NGQ1) » Definitions » Cyclically Adjusted PS Ratio

Medicure (FRA:NGQ1) Cyclically Adjusted PS Ratio : 0.46 (As of May. 01, 2025)


View and export this data going back to . Start your Free Trial

What is Medicure Cyclically Adjusted PS Ratio?

As of today (2025-05-01), Medicure's current share price is €0.59. Medicure's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was €1.28. Medicure's Cyclically Adjusted PS Ratio for today is 0.46.

The historical rank and industry rank for Medicure's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:NGQ1' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.34   Med: 1.53   Max: 15.43
Current: 0.42

During the past years, Medicure's highest Cyclically Adjusted PS Ratio was 15.43. The lowest was 0.34. And the median was 1.53.

FRA:NGQ1's Cyclically Adjusted PS Ratio is ranked better than
87.59% of 733 companies
in the Drug Manufacturers industry
Industry Median: 2.04 vs FRA:NGQ1: 0.42

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medicure's adjusted revenue per share data for the three months ended in Dec. 2024 was €0.379. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €1.28 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medicure Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Medicure's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Cyclically Adjusted PS Ratio Chart

Medicure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.09 0.71 0.65 0.78 0.45

Medicure Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.62 0.61 0.52 0.45

Competitive Comparison of Medicure's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicure's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medicure's Cyclically Adjusted PS Ratio falls into.


;
;

Medicure Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medicure's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.59/1.28
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicure's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Medicure's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.379/127.3637*127.3637
=0.379

Current CPI (Dec. 2024) = 127.3637.

Medicure Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.171 99.789 0.218
201506 0.187 100.500 0.237
201509 0.253 100.421 0.321
201512 0.389 99.947 0.496
201603 0.247 101.054 0.311
201606 0.315 102.002 0.393
201609 0.336 101.765 0.421
201612 0.254 101.449 0.319
201703 0.275 102.634 0.341
201706 0.303 103.029 0.375
201709 0.270 103.345 0.333
201712 0.173 103.345 0.213
201803 0.214 105.004 0.260
201806 0.287 105.557 0.346
201809 0.307 105.636 0.370
201812 0.329 105.399 0.398
201903 0.208 106.979 0.248
201906 0.274 107.690 0.324
201909 0.254 107.611 0.301
201912 0.166 107.769 0.196
202003 0.181 107.927 0.214
202006 0.160 108.401 0.188
202009 0.214 108.164 0.252
202012 0.173 108.559 0.203
202103 0.322 110.298 0.372
202106 0.337 111.720 0.384
202109 0.322 112.905 0.363
202112 0.459 113.774 0.514
202203 0.425 117.646 0.460
202206 0.373 120.806 0.393
202209 0.396 120.648 0.418
202212 0.386 120.964 0.406
202303 0.397 122.702 0.412
202306 0.397 124.203 0.407
202309 0.296 125.230 0.301
202312 0.332 125.072 0.338
202403 0.371 126.258 0.374
202406 0.335 127.522 0.335
202409 0.328 127.285 0.328
202412 0.379 127.364 0.379

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medicure  (FRA:NGQ1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medicure Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Medicure's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicure Business Description

Traded in Other Exchanges
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure Headlines

No Headlines